Amgen, Cytokinetics heart failure drug misses goal in study Reuters India AMSTERDAM (Reuters) - An experimental heart failure drug from Amgen and Cytokinetics missed its goal of improving shortness of breath in a mid-stage clinical trial, leaving its future uncertain. Shares in Cytokinetics fell 17 percent in pre-market ... |
